FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely faropenem (as faropenem sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely faropenem (as faropenem sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ranolazine 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely rupatadine (as rupatadine fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely rupatadine (as rupatadine fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pheniramine maleate 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pheniramine maleate 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely biperiden hydrochloride 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely biperiden hydrochloride 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 9 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely budesonide 9 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely clarithromycin (as clarithromycin citrate) 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin (as clarithromycin citrate) 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tacrolimus 750 microgram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 750 microgram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely finerenone 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely finerenone 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely finerenone 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely finerenone 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abemaciclib 150 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely abemaciclib 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abemaciclib 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely abemaciclib 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abemaciclib 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely abemaciclib 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely tolperisone hydrochloride 150 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely tolperisone hydrochloride 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely osimertinib (as osimertinib mesilate) 80 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely osimertinib (as osimertinib mesilate) 80 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely osimertinib (as osimertinib mesilate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely osimertinib (as osimertinib mesilate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely saroglitazar 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely saroglitazar 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely sodium bicarbonate 1 gram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely sodium bicarbonate 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely indapamide 2.5 milligram and perindopril erbumine 8 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier

Start Previous Page 72 of 153 Next End

This concept is not in any reference sets

Back to Start